Literature DB >> 29704866

Effects of Transfusion on Free Flap Survival: Searching for an Optimal Hemoglobin Threshold for Transfusion.

Min Ji Kim1, Kyong-Je Woo2, Bo Young Park2, So Ra Kang2.   

Abstract

BACKGROUND: Microsurgical free tissue transfer is a popular technique nowadays. Because of its considerably exquisite procedure, various risk factors can affect surgical outcome. However, current key practices, especially those in blood transfusion, are in contention due to the lack of enough evidence. Therefore, the objective of this study was to investigate the impact of perioperative blood transfusion on microsurgical complication.
METHODS: Data of a total of 168 patients who underwent microvascular free tissue transfer from 2013 through 2016 were retrospectively reviewed. Age, comorbidity, anatomical surgical site, preoperative and postoperative lowest hemoglobin (Hb) level, estimated blood volume loss, and final clinical flap outcome were compared between patients with and without transfusion treatment. Factors with a significance of p < 0.05 in univariate analysis were included in the multivariate logistic regression model to identify independent risk factors.
RESULTS: Of 168 patients, 72 (43%) were in the transfusion group. Cross analysis statistics showed that flap failure in the transfusion group was 3.6 times higher (p = 0.018) than that in the control group. Multivariable analysis revealed that age (p = 0.083) and perioperative lowest Hb level (p = 0.021) remained as significant predictors of flap failure. Receiver-operating characteristic curve analysis showed that the appropriate lower limit of transfusion commencement of Hb was 8.75 g/dL (area under the curve: 0.721).
CONCLUSION: A transfusion during perioperative period of free flap did not increase its failure rate. Rather than appropriate transfusion strategy, perioperative lowest Hb level, and age were significant predictors of flap failure. Therefore, transfusion can be confidently used in patients who undergo free flap without any hesitation. Results of this study provide practical evidence of performing perioperative transfusion for free tissue transfer patients. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29704866     DOI: 10.1055/s-0038-1648244

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  5 in total

Review 1.  Designing an evidence-based free-flap pathway in head and neck reconstruction.

Authors:  Michelle Mark; Michael Eggerstedt; Matthew J Urban; Samer Al-Khudari; Ryan Smith; Peter Revenaugh
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-04-27

2.  Sarcopenia is associated with blood transfusions in head and neck cancer free flap surgery.

Authors:  Alexander Joseph Jones; Vincent J Campiti; Mohamedkazim Alwani; Leah J Novinger; Brady Jay Tucker; Andrea Bonetto; Jessica A Yesensky; Michael W Sim; Michael G Moore; Avinash V Mantravadi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-01-31

3.  Thirty-Day Outcomes following Upper Extremity Flap Reconstruction.

Authors:  Thomas Wright; Daniel Donato; Jacob Veith; David Magno-Padron; Jayant Agarwal
Journal:  J Hand Microsurg       Date:  2020-09-17

4.  Big data analysis of the risk factors and rates of perioperative transfusion in immediate autologous breast reconstruction.

Authors:  Woo Jin Song; Hee Jin Kim; Nam Kyong Choi; Jung Ho Lee; Sang Gue Kang; Bommie Florence Seo
Journal:  Sci Rep       Date:  2022-03-29       Impact factor: 4.379

5.  Perioperative predictors of early surgical revision and flap-related complications after microvascular free tissue transfer in head and neck reconstructions: a retrospective observational series.

Authors:  John-Patrik Burkhard; Jelena Pfister; Roland Giger; Markus Huber; Claudia Lädrach; Manuel Waser; Radu Olariu; Dominique Engel; Lukas M Löffel; Benoît Schaller; Patrick Y Wuethrich
Journal:  Clin Oral Investig       Date:  2021-03-08       Impact factor: 3.573

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.